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Using specific antibody markers and double-label immu-
nofluorescence microscopy, we have followed the fate of 
progenitor cells in the sympathoadrenal (SA) sublineage of 
the neural crest in developing rat embryos. Such progenitors 
are first recognizable in the primordial sympathetic ganglia 
at embryonic day 11.5 (E 11.5), when they express tyrosine 
hydroxylase. At this stage, the progenitors also coexpress 
neuronal markers such as SCG 1 o and neurofilament, to· 
gether with a series of chromaffin cell markers called SA 1-
5 (Carnhan and Patterson, 1991 a). The observation of such 
doubly labeled cells is consistent with the hypothesis that 
these cells represent a common progenitor to sympathetic 
neurons and adrenal chromaffin cells. Subsequent to E 11.5, 
expression of the chromaffin markers is extinguished in the 
sympathetic ganglia but retained by cells within the adrenal 
gland. Concomitant with the loss of the SA 1-5 immuno-
reactivity in sympathetic ganglia, a later sympathetic neu-
ron-specific marker, 82, appears. In dissociated cell sus-
pensions, some 82+ cells that coexpress SA 1 are seen. This 
implies a switch in the antigenic phenotype of developing 
sympathetic neurons, rather than a replacement of one cell 
population by another. The SA 1 _, 82 transition does not oc-
cur for the majority of cells within the adrenal primordium. 
In vitro, most 82+ cells fail to differentiate into chromaffin 
cells in response to glucocorticoid. Instead, they continue 
to extend neurites and then die. Taken together, these data 
imply that the SA 1 _, 82 transition correlates with a loss of 
competence to respond to an inducer of chromaffin differ-
entiation. Thus, the development of SA derivatives is con-
trolled both by environmental signals and by changes in the 
ability of differentiating cells to respond to such signals. 
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An important problem in developmental neurobiology concerns 
the mechanism of diversification of the cell types that derive 
from the neural crest (Le Douarin, 1982). The dissection of this 
process has been aided by the use of monoclonal antibodies, 
which have proven useful tools for the study of neural devel-
opment (Mirsky, 1982; Reichardt, 1984). Such antibodies can 
provide molecular markers of differentiation and can reveal 
important differences between cells that are otherwise indistin-
guishable. The preceding article (Carnahan and Patterson, 1991 a) 
describes the generation and characterization of a novel set of 
monoclonal antibodies (SAl-5) that, in the postnatal rat, spe-
cifically label adrenal chromaffin cells, the major endocrine de-
rivative of the neural crest. These antibodies provide a set of 
reagents that can be used to identify chromaffin cells and their 
precursors in developing embryos. 
Studies of postnatal (Unsicker et al., 1978; Doupe et al., 
19 8 5a, b) and of embryonic chromaffin cells (Anderson and Axel, 
1986; Seidl and Unsicker, 1989a,b) have suggested that these 
adrenal medullary cells derive from a progenitor whose alternate 
fate is to become a sympathetic neuron. However, it has been 
difficult to establish whether this lineage relationship holds in 
vivo. To address this issue, we have examined in sections of 
developing rat embryos the pattern of expression of the chro-
maffin-specific sympathoadrenal (SA) antigens in relationship 
to that of neuron-specific markers. Neuronal markers in this 
lineage include intracellular proteins such as neurofilament 68 
kDa (NF68) (Cochard and Paulin, 1984) and SCG 10 (Anderson 
and Axel, 1985; Stein et al., l 988b), as well as cell surface 
antigens such as B2 (Anderson and Axel, 1986; Anderson, 1988). 
Because several of these markers are sequentially expressed in 
an overlapping manner, the developmental segregation of sym-
pathetic neurons and chromaffin cells from their precursor(s) 
can be traced in situ. 
We found that SAl + cells within the sympathetic ganglion 
primordium initially coexpress SCG l 0 and tyrosine hydroxy-
lase (TH), suggesting that they have the potential to become 
either sympathetic neurons or chromaffin cells. Subsequently, 
SA 1 immunoreactivity is lost and B2 immunoreactivity appears 
in these sympathetic neuroblasts. By contrast, this antigenic 
switch does not occur for most of the developing adrenal med-
ullary population. Experiments in vitro suggest that the SA l _, B2 
switch correlates with a loss of competence to respond to glu-
cocorticoids, and commitment to the neuronal pathway of dif-
ferentiation. 




Figure I . Initial expression of SA I occurs in developing sympathetic ganglia. Sections are through sympathetic ganglion primordia, at E 11.5. The 
same section was doubly labeled with SAi (A) and TH (B). The same section was doubly labeled with SAi (C) and polyclonal anti-SCGIO (D). 
Arrows indicate individual doubly labeled cells. E and F, Higher-magnification view illustrating two process-bearing cell bodies (arrows) doubly 
labeled by SA I (E) and SCG l O (F). Arrowheads indicate the process from one cell, which is also doubly labeled. Asterisk in C and D indicates 
autoftuorescent blood cells in the dorsal aorta. The specific staining patterns illustrated were not observed in controls lacking primary. antibody. 
Scale bars, 33 µm. 
Materials and Methods 
Immunocytochemistry. Staged embryos were fixed in 4% paraformal-
dehyde, embedded, and sectioned in a cryostat as described previously 
(Carnahan and Patterson, 199 la). Double labeling was performed using 
an SA 1 ascites fluid diluted l :2000, together with undiluted B2 hybrid-
oma supernatant (a gift from J. Dodd, Columbia University), polyclonal 
rabbit anti-TH diluted 1:250 (Eugene Tech Inc., Allendale, NJ), or 
polyclonal rabbit anti-SCG 10 diluted l :250 (Stein et al., l 988a). Sec-
tions were incubated overnight at 4°C with primary antibody, in the 
presence of 1 % normal goat serum (NGS) and 0.1 % Nonidet P-40. After 
thorough washing to remove unbound primary antibody, sections in-
cubated with SAi plus anti-TH or with SAi plus anti-SCGIO were 
developed using rhodamine-conjugated goat anti-rabbit IgG at 1:500 
plus ftuorescein isothiocyanate (FITC)-conjugated goat anti-mouse lgG 
at 1:200 (TAGO, Inc., Burlingame, CA). Sections incubated with SAi 
plus B2 were developed using rhodarnine goat anti-mouse IgM (T AGO) 
and ATC-conjugated goat anti-mouse lgG (Southern Biotech, Inc., At-
lanta, GA), both at 1:100. To reduce nonspecific binding, dilutions of 
secondary antibody were precleared by incubating for 1 hr at 4°C in 
10% normal rat serum plus 5% NGS, and then centrifuged for 10 min 
at 14,000 x g. Controls lacking primary antibody exhibited no specific 
staining. Sections were mounted in para-phenylenediamine/glycerol and 
examined with an Olympus OMT-2 inverted microscope. All micro-
graphs in this article illustrating SAl versus B2 staining were photo-
graphed and printed using identical exposure times, so that staining 
intensity is directly comparable among the figures. For the detection of 
phenylethanolamine N-methyl transferase (PNMT) immunoreactivity, 
a rabbit anti-PNMT antiserum (the generous gift of Dr. Martha Bohn, 
University of Rochester) was used at a dilution of I: 1000 and visualized 
using an FITC-conjugated goat anti-rabbit lgG secondary antibody 
(T AGO) at I :200. 
Isolation and culture of B2+ and B2- cells by FAGS. B2+ cells were 
isolated from dissociated suspensions of embryonic day 14.5 (El4.5) 
adrenal glands by surface labeling and fluorescence-activated cell sorting 
(FACS) as previously described (Anderson and Axel, 1986). B2- cells 
were isolated using monoclonal antibody HNK-1 (Abo and Balch, 1981), 
which labels all TH+ cells within the El4.5 adrenal gland (Anderson 
and Axel, 1986; Birren and Anderson, 1990). We used HNK-1 rather 
than the SA(l,2,4) cocktail (Carnahan and Patterson, 1991b) to isolate 
B2- progenitors, because the SA antigens are poorly expressed on the 
cell surface in E14.5 adrenal suspensions (J. F. Carnahan, unpublished 
observations). As all B2+ cells are also HNK-1 +, however, in order to 
isolate the B2- fraction the B2+ cells first had to be eliminated by 
complement lysis using monoclonal antibody B2. The remaining B2-
cells were then labeled with HNK-1 ascites diluted 1:500 and FITC-
conjugated goat anti-mouse lgM (TAGO). Virtually all HNK-1 +, B2-
cells are TH+, and over 80% are SAi +,indicating that HNK-1 (in com-
bination with B2 elimination) is a sympathoadrenal lineage surface 
marker comparable to the SA antibodies, for the E14.5 adrenal gland. 
B2+ and HNK-1+ (B2-) cells were separated from unlabeled cells by 
FACS using an Ortho instrument (Becton-Dickinson, Inc., Mountain-
view, CA). Approximately 1-2% of the input cells were B2+, while 6-
7% were B2-, HNK-1 +. Cells were cultured on a collagen/poly-o-lysine/ 
laminin substratum in steroid-stripped L-15-C02 complete medium as 
previously described (Anderson and Axel, 1986), except that fetal calf 
serum was substituted for rat serum. When included, dexamethasone 
(DEX) was diluted from a stock solution of 10-3 M in 95% ethanol, to 
a final concentration of 1 µM. For quantifying the inhibition of process 
outgrowth, a cell cluster was defined as "process bearing" if any cyto-
plasmic extension could be detected originating from the cluster. It was 
not possible to determine whether every cell in a cluster was process 
bearing, because the tight clumping of the cells precluded assignment 
of processes to individual cells. Nonetheless, for the purposes of this 
study this measurement represents a highly stringent criterion, in that 
only clusters containing exclusively rounded cells were counted as non-
process bearing. Any systematic error introduced by this method would, 
if anything, underestimate the difference in process outgrowth between 
B2- and B2+ cells. For single-cell tracking experiments, cells were iden-
tified 24 hr after plating and their positions marked by means of a 
gridded coordinate system embossed in the bottom of the dish using a 
BB press. Cells were photographed at that time and every 24 hr thereafter 
for the next 2 d. 
Results 
Transient coexpression of neuronal- and chromaffin-specific 
markers by cells in embryonic sympathetic ganglia 
In the postnatal rat, the SAl-5 series of monoclonal antibodies 
specifically labels adrenal chromaffin cells but not sympathetic 
neurons (Carnahan and Patterson, 1991a). In developing em-
bryos, however, expression of the SAI antigen is detectable in 
cells of the primordial sympathetic ganglia, beginning at El 1.5 
(Fig. IA; see also Carnahan and Patterson, 199 la). At this time, 
neural crest cells have aggregated in clusters adjacent to the 
dorsal aorta and can be recognized by their expression of TH, 
a lineage marker for adrenergic neural crest derivatives (Cochard 
et al., 1979). Double labeling indicates that all SAl +cells appear 
to coexpress TH, and vice versa (Fig. lB). No expression of 
SA 1 can be detected in premigratory or in migrating neural crest 
cells 1 d earlier in development (data not shown). 
The initial expression ofSAl coincides not only with that of 
TH, but also with that ofneural-specific markers such as SCG 10 
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(Anderson and Axel, 1985; Stein et al., 1988b) and NF68 (Co-
chard and Paulin, 1984). To determine whether such neuronal 
markers are coexpressed in the same cells that express SAl, 
double-label immunohistochemistry was performed using a rab-
bit anti-SCG 10 antibody (Stein et al., l 988b), mouse monoclo-
nal SAI antibody, and species-specific secondary antibodies. 
Within the ganglionic cluster, SCG 10 (Fig. ID) is expressed in 
an overall pattern that is coextensive with that of SA 1 (Fig. 1 C). 
At higher magnification (Fig. 1E,F), individual cells labeled by 
both anti-SCG 10 and SA 1 are visible; many of these cells are 
process bearing (Fig. lE,F, arrows). It is difficult to determine 
whether all SA!+ cells are also SCGlO+, however, because the 
SCGlO antigen is membrane bound (Stein et al., 1988b) and 
concentrated in the perinuclear region (Fig. lD, arrow) whereas 
the SAI antigen exhibits a punctate, cytoplasmic distribution 
(Fig. IC, arrowhead). Nevertheless, a substantial number of 
double-positive cells can be observed. For technical reasons, 
double labeling with monoclonal SAl and NF68 antibodies was 
not possible. However, the timing of TH and NF68 appearance 
is coincident (Cochard et al., 1979; Cochard and Paulin, 1984), 
and TH and NF68 are coexpressed in SA precursors (Anderson 
and Axel, 1986). It is therefore likely that SAl +ganglionic cells 
coexpress NF68 as well as SCG 10. 
The coexpression of SA I, TH, and SCG 10 in individual gan-
glionic cells persists through E 12. 5 (Fig. 2A-D). After this time, 
the expression of SA 1 in the sympathetic ganglia begins to de-
cline (see also Carnahan and Patterson, 199 la). However, ex-
pression of SCG 10, TH, and NF is maintained, as previously 
described (Cochard et al., 1979; Cochard and Paulin, 1984; 
Anderson and Axel, 1986). 
Cells in sympathetic ganglia begin to express B2 coincident 
with the loss of SAJ 
Previously, monoclonal antibody B2 (J. Dodd, unpublished ob-
servations) was shown to label specifically a population of neu-
ronal precursors in El 4.5 sympathetic ganglia, as well as a subset 
of cells within the adrenal gland (Anderson and Axel, 1986). As 
B2, like the SA antibodies, appears to be highly specific for cells 
of the SA lineage, it was of interest to determine the relative 
timing of expression of these two markers. In contrast to SA l, 
no staining with B2 can be detected in sympathetic ganglia, or 
elsewhere in the embryo, at El 1.5 (not shown). At El2.5, faint 
patches of punctate B2 staining can occasionally be seen (Fig. 
2F). These patches overlap some of the SAl + cells (Fig. 2E). 
Over the next few days of development (E13.5-15.5), the in-
tensity of B2 expression in the sympathetic ganglia increases, 
while that of SAl decreases (compare exposure-matched Figs. 
2F, 3B, 4B), until SAl expression appears completely replaced 
by that of B2. 
The increase in B2 expression appears to occur in a rostro-
caudal gradient, with more anteriorly located ganglia (Fig. 3B) 
expressing higher levels than those located more posteriorly (Fig. 
3D). SAl staining does not appear to fade in a complementary 
rostrocaudal manner, however (Fig. 3A,C). Within "transition-
al" sympathetic ganglia at El4.5, a complementary pattern of 
SA l and B2 expression is seen: regions of a given ganglion that 
are high in SAl (Fig. 4A, arrow) are low in B2 (Fig. 4B, arrow); 
conversely, regions that are high in B2 are low in SAl (Fig. 
4A,B). However, the overall domains ofSAl and B2 expression 
in such ganglia appear roughly coextensive. By El5.5-16.5, 
however, virtually all detectable SAi staining has disappeared, 
and the ganglia are uniformly strongly B2+. Taken together, these 




Figure 2. Coexpression of SAi with TH and SCGIO in EI2.5 sympathetic ganglia. A and B, C and D. and E and F represent doubly labeled 
sections stained with the antibodies indicated below the panels. In all cases, the ftuorochrome used for SA I was FITC. In F, a faint patch of punctate 
B2 staining can be detected in a region containing SA 1 + cells (arrow, E and F). However, many ganglia showed no detectable staining with B2 at 
this stage of development. Asterisks indicate autoftuorescent blood cells . . Scale bar, 33 µm. 
data indicate that expression ofB2 occurs subsequent to that of 
SA 1 during SA development but that there is a period of tran-
sient overlap between these two markers. 
The SAJ--+ B2 transition does not occur in the adrenal medulla 
Chromaffin cells derive from SA progenitors that continue mi-
grating from the vicinity of the sympathetic ganglia to invade 
the adrenal gland primordium. This invasion begins between 
E 13.5 and El 4.5 (Bohn et al., 1981; Teitelman et al., 1982). 
These invading progenitors express SA 1 (not shown). In contrast 
to their counterparts in the sympathetic ganglia, however, they 
appear for the most part to maintain expression of this antigen 
after settling within the adrenal (Fig. 4C). For example, at El 4.5, 
many cells expressing high levels of SA 1 can be observed deep 
within the adrenal gland (Fig. 4C,E; arrowhead), whereas in the 
adjacent sympathetic ganglion virtually no SAi staining is de-
tectable (Fig. 4C, arrow). Conversely, the sympathetic ganglia · 
exhibit a high level of B2 labeling (Fig. 4D, arrow), whereas 
only faint B2 staining is detected within the adrenal gland. In 
some sections, areas of intense B2 staining could be observed 
within the adrenal primordium (Fig. 4F, arrowhead). However, 
these regions correspond to the future extraadrenal ganglionic 
complex (EAGC) (Lempinen, 1964), a structure that segregates 
from the adrenal gland proper and eventually degenerates to-
ward the end of gestation (Aloe and Levi-Montalcini, 1979). 
Cells classified as "chromaffin cells" by histochemical stains 
have been identified in the embryo in locations outside of the 
adrenal gland (Lempinen, 1964). Such "extraadrenal chromaffin 
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SA-1 82 
Figure 3. Initial appearance of 82 in sympathetic ganglia. A and B, and C and D represent doubly labeled sections through two different axial 
levels in the trunk region of an El3.5 embryo. The A,B pair lies more anterior (rostral) than the C,D pair. A and C were photographed and printed 
using identical exposure times, as were B and D. Note that the 82 staining in B overlaps the region of the sympathetic ganglion containing SAi • 
cells in A. The 82 staining shows a characteristic punctate appearance. In the more caudally located ganglion (D), the intensity of 82 staining is 
much weaker (compare with B). Compare the intensity of 82 staining in B to that in Figure 2F, one day earlier in development. Arrowheads (C 
and D) indicate SAi • cells that exhibit faint 82 labeling. da, dorsal aorta. Scale bar, 33 µm. 
cells" also appear to undergo the SA I - B2 transition, like the 
cells in the sympathetic ganglia but unlike those within the 
adrenal gland (Fig. 5). For example, clusters of cells expressing 
SAi can be observed in the paraaortic region (Fig. 5A, arrows) 
at E14.5. Patches ofB2• cells are present in some, but not all, 
of these SA 1 • paraaortic clusters (Fig. 5B, arrows). At higher 
magnification, the domains of B2 and SA l staining appear to 
be partially overlapping (Fig. 5C,D; arrow), similar to the pat-
terns in the transitional sympathetic ganglia (see above). 
The appearance of B2 correlates with a loss of competence for 
chromaffin differentiation 
The foregoing data indicated that neuroblasts in the sympathetic 
ganglia undergo a developmental change beginning on E13.5, 
in which they gradually extinguish expression of SA l and ac-
quire expression ofB2. By contrast, this change does not appear 
to occur for the majority of cells that migrate to the adrenal 
gland. In order to determine whether this change in antigenic 
phenotype reflects changes in the developmental properties of 
sympathoadrenal progenitors, we studied in culture the behavior 
of B2+ and B2- cell populations isolated from El4.5 adrenal 
glands. The adrenal gland was chosen for this experiment be-
cause previous studies had indicated that, in addition to the 
majority B2- chromaffin precursor population, a subset of 82+ 
cells is present (Anderson and Axel, 1986; see also Fig. 4F); 
thus, both populations can be obtained from the same tissue. 
After isolating the B2+ cells, the B2-, TH+ cells were separated 
from non-SA lineage B2- cells using monoclonal antibody 
HNK- l (see Materials and Methods). This antibody identifies 
SA lineage cells in the adrenal gland, since all HNK-1 .. cells are 
also TH+ (Birren and Anderson, 1990). The majority (over 80%) 
of the B2-, HNK-1 +cells are also strongly SAi+, as determined 
by staining of fixed, permeabilized cells (n = 300). By contrast, 
81 % of freshly isolated B2+ cells are SAI-. This immunochem-
ical fractionation thus separated the SA progenitor population 
from the E14.5 adrenal gland into predominantly B2+, SAI-
and B2-, SAI+ cells. 
B2 .. cells appeared more advanced in their state of neuronal 
differentiation, and less able to develop into chromaffin cells, 
than the B2- , SAl + cells. For example, after 24 hr in culture, 
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Figure 4. The SA1 - B2 switch occurs in sympathetic ganglia, but not in the adrenal gland. A and B, Doubly labeled pair from a section through 
an El4.5 sympathetic ganglion. Note that the levels ofB2 staining by this stage are quite high (compare with exposure-matched Figs. 2F and 40,D). 
Note also that faint SA I staining in A can still be detected in the region of the ganglion that is strongly B2•. The arrows indicate a region that is 
still strongly SAi + (A), but weak for B2 (B). C and D, and E and F represent doubly labeled pairs from two nearby sections through the adrenal 
gland at El4.5. The arrowheads (C and E) indicate strongly SAi + chromaffin cells deep within the adrenal medullary region. Note that these same 
regions are negative or only faintly positive for B2 (D and F). The arrows ( C and D) indicate the nearby sympathetic ganglion; note the intense B2 
staining (D) and low SAl staining (C). In F, the arrowhead indicates a patch ofB2• in the region that will become the EAGC; note that this region 
also contains some brightly SA!+ cells. Photographic exposure times are identical with those in Figures 2 and 4 (E and F) for SAl and 82, 
respectively. Scale bar, 63 ,um. 
81 % ofB2+ cell clusters were process bearing, whereas only 4 7% 
of the B2- clusters bore neurites (Fig. 6A, NO ADD). In addition, 
the processes on B2• cells tended to be longer, on average, than 
those on B2- cells (Anderson, 1988). By day 3, however, 76% 
of cell clusters in the B2- population had extended processes 
(data not shown), indicating that most if not all of these cells 
are neuronal precursors but that their differentiation lags behind 
that of the B2• cells. 
The two cell populations also differed significantly in their 
ability to differentiate into chromaffin cells, as assessed by mor-
phology and antigenic phenotype, in response to the synthetic 
glucocorticoid DEX. For example, after 24 hr of culture in 1 
µM DEX, the majority of B2- cell clusters exhibited a round, 
chromaflin morphology; only 13% were process bearing (Fig. 
6A, DEX, B2-). By contrast, under these same conditions, over 
60% of the B2• cells bore neurites (Fig. 6A, DEX, B2•). Thus, 
DEX inhibited process outgrowth 72% in the B2- population, 
but only 24% in the B2• population. Cbromaffin differentiation 
was also assessed by staining cells with antibodies to the chro-
maffin-specific marker enzyme PNMT. After 3 d of culture in 
DEX, over 80% of the B2- cells exhibited PNMT immuno-
reactivity, whereas less than 50% of the 82+ cells expressed 
PNMT (Fig. 6B). Taken together, these data indicate that the 
B2- population is less advanced in neuronal differentiation, and 




Although the B2+ population on average is more advanced 
in neuronal differentiation than the 82- population, at the single 
cell level it is heterogeneous. Previous studies indicated that 
many B2• cells continue to extend neurites and then die in 
glucocorticoid but that a subset of cells can undergo chromaffin 
differentiation (Anderson and Axel, 1986). Serial observations 
of identified cells now indicate that these two subpopulations 
can be identified prospectively by their different morphologies. 
82 
B2 
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Figure 5. Expression of SAi and B2 
by extraadrenal chromaffin cells in the 
paraaortic region. A and B, and C and 
D represent doubly labeled pairs from 
two nearby sections through the lumbar 
region of an El4.5 embryo, posterior to 
the region containing the adrenal gland. 
Arrowheads in A indicate the sympa-
thetic ganglia. da, dorsal aorta. Arrows 
in B indicate patches ofB2• cells in the 
paraaortic region; some of these patch-
es are also SA I• in A (arrows). Note, 
however, a large SAi + patch in A (left 
arrow) that is not labeled by 82 in B. 
Similar patches in other sections are also 
labeled by anti-TH and anti-SCG l 0 (not 
shown). C and D are a higher-magni-
fication view of paraaortic cells. Note 
the large patch of SA I+ cells that is not 
labeled by B2 (D, arrow), and the in -
tense B2 staining that overlaps the SA l • 
region. Scale bar: 134 µm for A and B; 
33.5 µm for C and D. 
We followed the fates of 72 individual B2+ cells in low-density 
cultures with DEX, over a 3 d period. Forty-three of these cells 
were initially process bearing; of those, 86% died over the en-
suing culture period (Fig. 7, arrow). The process-bearing cells 
that survived did not express detectable PNMT (not shown). 
On the other hand, of the 19 cells that survived and displayed 
a chromaffi.n phenotype, 84% derived from precursors initially 
lacking processes (Fig. 7, arrowhead). (The remaining 16% de-






























Figure 6. B2• cells show a reduced capacity for chromaffin differen-
tiation compared to B2- cells. B2• and B2- (HNK-1 •)cells were isolated 
from E14.5 adrenal glands (see Materials and Methods) and cultured 
with (DEX) or without (NO ADD) I µM DEX. A, After 24 hr in culture, 
the population was scored for the percentage of cell clusters bearing 
processes (see Materials and Methods). Only the TH• cell population 
was counted; contaminating flat cells were not included. Note that in 
DEX, only 13% of B2- clusters had processes, whereas 61 % of 82• 
clusters had processes. The method of analysis probably underestimates 
the difference between B2• and B2- cells (see Materials and Methods). 
B, After 3 d in culture, the population was fixed and stained with an 
anti-PNMT antibody, and the percentage of surviving cells expressing 
PNMT was determined. Time course experiments indicate that most 
cells that can express PNMT have done so by 3 d of culture in DEX 
(Michelsohn and Anderson, unpublished observations). Data are the 
mean ± SEM of four to six determinations from two independent ex-
periments. 
rived from cells initially bearing short processes.) These data 
indicate a strong correlation between the initial morphology of 
B2+ cells and their response to glucocorticoid: cells with short 
processes or a round morphology are likely to survive and dif-
ferentiate into chromaffin cells, whereas process-bearing cells 
are likely to continue to extend neurites and then die. The re-
sponse of SA precursors to glucocorticoid can therefore be pre-
dicted based upon a combination of cell morphology and an-
tigenic phenotype. 
Expression of SAJ and B2 in late gestational embryos 
The preceding observations revealed a good correlation between 
the position of SA lineage cells in the embryo and their antigenic 
phenotype, around £14.5-15.5. Cells that migrate to the adrenal 
gland maintain expression of SA I and do not induce B2, whereas 
cells that migrate to the sympathetic ganglia extinguish expres-
sion of SA I and induce B2. At later stages of gestation, however 
(ca. EIS.5), some violations of this "rule" were observed. For 
example, scattered patches of B2+ cells can be observed deep 
within the adrenal medulla (Fig. SB). Conversely, patches of 
SAi + cells can be observed outside of the adrenal microenvi-
ronment, in the EAGC (Fig. SC). The EAGC also contains 
patches of brightly stained B2+ cells (Fig. SD, arrow). However, 
these patches exhibit a complementary, nonoverlapping distri-
bution relative to the patches of SA 1 +cells (Fig. SD, arrowheads; 
compare to 8C). Thus, the mutual exclusivity of high B2 and 
high SAi labeling persists, despite the fact that some cells of 
each phenotype appear in the "inappropriate" location. 
The SAi +and B2+ patches can also be distinguished by their 
relative levels of TH expression: SAi + patches are intensely 
stained with anti-TH antibody (Fig. 8£,F), whereas B2+ patches 
are more weakly stained (not shown). B2+ patches, conversely, 
stain more intensely than SA l + patches with neuronal markers 
such as SCG 10 and NF68 (not shown). This pattern of marker 
expression supports the idea that the B2+ patches contain cells 
with a more neuronal phenotype than the SA I+ patches. 
Discussion 
Evidence for a bipotential SA progenitor in vivo 
Neural crest cells in the ventrolateral migration pathway make 
a late developmental decision between the expression of an 
endocrine or a neuronal phenotype. In vitro studies (Doupe et 
al. , l 985b; Anderson and Axel, 1986; Seidl and Unsicker, I 989b; 
Carnahan and Patterson, 1991 b) have provided evidence that 
this decision is made by a progenitor cell whose choice of cell 
fate is determined, at least in part, by environmental factors. 
However, it has been difficult to verify this lineage relationship 
in vivo, because of the difficulties involved in tracing the fates 
of migratory cells in the mammalian embryo. In this study, we 
report the observation that at least some cells in embryonic 
sympathetic ganglia transiently coexpress neural-specific and 
chromaffin-specific markers. Cells that remain in the ganglion 
primordia lose expression of the chromaffin markers (SAl-5) 
and retain expression of the neuronal markers. Conversely, cells 
that migrate to the adrenal primordium lose expression of the 
neuronal markers (Anderson and Axel, 1986; Vogel and Weston, 
1990) and retain expression ofSAI-5. These data are consistent 
with the idea that the transiently dual-phenotype cells are bi-
potential progenitors of chromaffin cells and sympathetic neu-
rons, which selectively repress expression of the neuronal or 
chromaffin markers according to their final choice of cell fate. 
An alternative explanation is that the disappearance of SA l 
immunoreactivity from the ganglion primordium at El4.5 is 
due to the death or emigration of SA I+ cells. This seems unlikely, 
because initially the SAi +cells are also TH+ and SCGlO+, and 
cells with a TH+, SCG 10+ phenotype remain in the ganglia even 
as SAi disappears. Moreover, we observe the concomitant ap-
pearance of a second marker, B2, in cells that are still weakly 
SAi +(see below). Thus, the cells that are initially SAi +appear 
to remain in the ganglion primordium and to change their an-
tigenic phenotype, rather than to disappear. Furthermore, the 
isolation of SA I+ cells from E 13. 5 sympathetic ganglia has re-
vealed that 90% of these cells initially express neurofilament 
140 kDa and that these cells have the capacity to develop either 
into chromaffin cells or sympathetic neurons, depending upon 
culture conditions (Carnahan and Patterson, 1991 b). Taken to-
gether, these data indicate that the SAi + , SCGlQ+ cells observed 
in embryonic sympathetic ganglia are likely to be precursors of 
sympathetic neurons in vivo. 
The phenomenon of transient marker coexpression followed 
by mutually exclusive segregation is reminiscent of several other 
cell lineages, wherein bi- or multipotential progenitors have 
been shown to give rise to closely related but distinct cell types. 
In the immune system, for example, CD4+ and CD8+ peripheral 
T-lymphocytes have been shown to derive from a progenitor 
that is initially double positive for both of these cell-surface 
markers (Carbone et al., 1988; Fowlkes et al., 1988). In the 
pituitary gland, somatotrophs expressing growth hormone and 
lactotrophs expressing prolactin are thought to develop from 
precursors that transiently coexpress both hormones (Hoeffter 
et al., 1985). Finally, in the endocrine pancreas, embryonic islet 
progenitor cells have been shown to initially coexpress peptides, 
such as insulin and glucagon, which later segregate to different 
subpopulations of mature endocrine cells (Alpert et al., 1988). 
This phenomenon could reflect the fact that the coexpressed 
genes are regulated, in part, by transcription factors that are 
common to all cells of a given lineage (Bodner et al., 1988; 
Ingraham et al. , 1988). The later restriction of these markers to 
different subtypes of cells within the lineage could reflect the 
superposition of additional regulatory mechanisms, which fine-
tune the pattern of gene expression. In the SA lineage, for ex-
ample, the expression of neuronal markers such as SCG 10 can 
be upregulated by fibroblast growth factor (FGF) and NGF (fac-
tors which promote neuronal differentiation) and downregulated 
by glucocorticoid (which promotes chromaffin differentiation) 
(Stein et al. , l 988a). Conversely, chromaffin-abundant markers 
such as TH (Fig. 8£,F) are upregulated by glucocorticoid and 
downregulated by NGF (Leonard et al., 1987; Stein et al., l 988a). 
In this way, a repertoire of lineage-specific gene expression es-
tablished in progenitor cells by a common transcriptional pro-
gram may be fine-tuned by differences in local environment, 
generating further phenotypic diversification. 
Developing sympathetic neuroblasts undergo a switch in 
antigenic phenotype 
Our antibody markers revealed a relatively late developmental 
event in the differentiation of sympathetic ganglionic neuro-
blasts: as expression of the SAi antigen declines, the cells induce 
the expression of a surface antigen recognized by monoclonal 
antibody B2. At intermediate times, both SAi and B2 are ex-
pressed in the same ganglia, and the pattern of expression of 
these two markers appears coextensive. Eventually, SAi ex-
pression becomes undetectable and the cells in the ganglia uni-
formly express high levels of B2. This pattern strongly suggests 
that the SA 1-+ B2 transition reflects a change in marker ex pres-
-+ 
Figure 7. B2• cells bearing processes fail to respond to glucocorticoid. 
Individual B2• cells were identified 24 hr after plating in I µM DEX 
and photographed every 24 hr for the next 2 d. Numhers indicate hours 
of culture. Arrows indicate an example of a pair of process-bearing cells 
that failed to respond to DEX. Note at 48 hr the phase-bright pycnotic 
figures near the remaining two phase-gray living cells, suggestive of cell 
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division followed by cell death. At 72 hr, only a single pycnotic figure 
is visible (arrow). The arrowhead indicates an example of a non-process-
bearing cell (or cell cluster) that survived and displayed a rounded 
chromaffin morphology. Antibody staining indicated that cells of this 
phenotype were PNMT• (not shown). Note that process-bearing cells 
were also observed to die in cultures lacking DEX (not shown), indi-
cating that the death of these cells is not caused by glucocorticoid. The 
extent of cell death is greater in the low-density cultures used in these 
single-cell tracking experiments than in the mass cultures used in pop-
ulation experiments; therefore, the results of the two types of experi-
ments are not quantitatively comparable. 




Figure 8. Patches of B2• and SAI • cells that violate the positional "rule." Shown are sections from an E18.5 embryo. A and B, Doubly labeled 
pair through the adrenal gland. Note the large patch of 82• cells (B), which is SA 1- (A). In A, the SA 1 staining is obscured by a high level of 
autofluorescence but is clearly visible as punctate labeling at the margin of the B2• zone. C and D, Doubly labeled pair through the extraadrenal 
ganglionic region. Note the intensely stained patch of B2• cells (arrow, D), which is SA 1- (arrow, C). Arrowheads in D indicate two less-intensely 
stained B2• patches, which flank a SAi • patch (C). E and F, Doubly labeled pair through an EAGC, illustrating adjacent patches of SAi +, TH"1 
cells, and SAi- , Th10 cells. The SAi- patches would be 82• (as, e.g., in C and D, arrowheads). Scale bar, 62 µm. 
sion within a single population of cells, rather than the replace-
ment of one population by another. This interpretation is re-
inforced by the complementary patterns of SA I and B2 staining 
seen within individual transitional ganglia: regions that are in-
tensely SA I• are weakly B2+, and vice versa. Such nonhomo-
geneous staining further suggests that the SA 1 ... B2 switch occurs 
asynchronously for cells within a given ganglion. 
The SAi -+ B2 transition provides an indication that the cells 
of the developing sympathetic ganglia are changing, in a way 
that is not otherwise detectable in vivo. In what way are the cells 
changing? The fact that expression of SA l precedes that of B2 
suggests that cells expressing the former antigen are at an earlier 
stage of neuronal differentiation than cells expressing the latter. 
Consistent with this idea, cells isolated by sorting with a cocktail 
of SA antibodies have a rounded morphology (Carnahan and 
Patterson, 1991 b), whereas cells isolated by sorting with B2 tend 
to extend processes shortly after plating (Anderson, 1988). 
Moreover, most B2-, SAi • cells can be induced to differentiate 
into chromaffin cells at high frequency by glucocorticoid (see 
also Carnahan and Patterson, 1991 b ). By contrast, process-bear-
ing B2• ceUs are refractory to such an induction. As demon-
strated previously (Anderson and Axel, 1986), a minority ofB2+ 
cells remain responsive to glucocorticoid, but most of these cells 
initially exhibit a rounded morphology. The developmental het-
erogeneity within the adrenal B2+ population is consistent with 
the fact that 19% of freshly isolated B2+ cells express SA 1. This 
could reflect the gradual nature of the SAi .... B2 transition, as 
suggested by the overlapping expression of SA I and B2 in sec-
tions of El4.5 sympathetic ganglia. Nevertheless, cells with a 
B2+, SAI - antigenic phenotype and a process-bearing mor-
phology have lost competence to respond to glucocorticoid and 
appear committed to neuronal differentiation (Fig. 9). The loss 
of responsiveness to glucocorticoid may serve to "insulate" im-
mature sympathetic neurons from the steep rise in circulating 
fetal corticosterone levels, which begins on El6.5 (Teitelman et 
al., 1982). Loss of competence is thought to be a feature of 
inductive processes in other embryonic systems (Gurdon, 1987; 
Grainger and Gurdon, 1989). 
Control of the SA J .... B2 transition 
Cells that arrest migration in the sympathetic ganglia extinguish 
SA I and induce B2, whereas those t hat migrate into the adrenal 
primordium mostly fail to make this switch. Instead, chromaffin 
cells maintain expression of SAi into adulthood. This obser-
vation suggests that the SAI - B2 switch may be controlled by 
factors in the microenvironments encountered by SA progeni-
tors. SA antigen- positive progenitors from sympathetic ganglia 
reduce levels of SAi expression in the absence of DEX but 
maintain expression in the presence of DEX (Carnahan and 
Patterson, 199 1 b). Moreover, chromaffin cells from neonatal 
rats lose SA staining in the presence of NGF and absence of 
glucocorticoid (Carnahan and Patterson, 199 Ia). These in vitro 
results suggest that in vivo, progenj tors within the adrenal pri-
mordium may be prevented from undergoing the SA l - B2 tran-
sition by the high local concentration of adrenal corticosteroids. 
The SA 1- B2 transition may also be promoted by factors that 
stimulate neuronal differentiation, such as FGF and NGF 
(Stemple et al. , 1988; Birren and Anderson, 1990; Carnahan 
and Patterson, 199lb). 
The maintenance of SAl and fai lure to induce B2 are first 
apparent in the adrenal gland as early as El 4.5 (Fig. 4), sug-
gesting that glucocorticoids and their receptor are functional at 
this early stage. mRNA encoding the glucocorticoid receptor 
has been detected in the adrenal gland as early as El 5.5 (An-
derson and Michelsohn, 1989). However, using a radioligand 
binding assay, Seidl and Unsicker ( l 989b) have reported that 
glucocorticoid receptor is undetectable in adrenal medullary 
precursors prior to E 16.5. The reason for this apparent discrep-
ancy is not clear. Chromaffin precursors may contain a low level 
ofreceptor that is sufficient to mediate the inhibition ofneuronal 
d ifferentiation; alternatively, the SA 1- B2 transition may be 
suppressed in the early adrenal gland by factors other than ste-
roid hormones. However, recent radioimmunoassay data in-
dicate that the El 4.5 adrenal gland contains micromolar quan-
tities of glucocorticoid (A. Michelsohn and 0 . J. Anderson, 
unpublished observations). Whatever the case, the SA 1 and B2 
markers provide evidence that progenitors in the adrenal gland 
are phenotypically distinct from their ganglionic counterparts 2 
d before they express PNMT, the only other marker previously 
able to distinguish chromaffin cells from sympathetic neurons 
(Bohn et al., 1981; Teitelman et a l., 1982). 
The correlation between the antigenic phenotype of SA pro-
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Figure 9. Schematic diagram illustrating sequence of antigenic changes 
in the SA lineage. The earliest bipotential progenitors are SA I• and 
B2-. They coexpress neuron-specific markers such as SCG 10 and chro-
maffin-specific markers such as SA 1-5, as illustrated by the crosshatch-
ing. In this study, progenitor celJs were isolated from El4.5 adrenal 
glands using monoclonal antibody HNK-1 in combination with 82-
mediated complement lysis. Most but not all of these cells are also SA I •; 
those cells lacking SAi may have initiated neuronal differentiation. ln 
the absence ofg)ucocorticoids, these progenitors differentiate along the 
neuronal pathway, a process promoted by FGF and perhaps other, as 
yet unidentified factors. Cells that are B2• and SA 1- and that bear 
processes have lost competence to respond to glucocorticoid (com milled 
neuroblast). For clarity, intermediate stages of development between 
tile bipotential progenitor and committed neuroblast are omitted. 
genitors and their location in the embryo is not perfect: occa-
sional clusters ofB2• cells can be found within the adrenal gland, 
and clusters of SA I• cells are found outside ofit, late in gestation. 
T he B2• clusters probably correspond to clusters of 
Neuropeptide Y• cells observed by Henion and Landis (1990). 
Similar clusters of cells with a neuronal phenotype have been 
found within the human feta l adrenal gland as well (Cooper et 
al., 1990). Our in vitro results provide a possible explanation 
for this phenomenon: these 8 2+ neuronal cells derive from pre-
cursors that have lost competence to respond to glucocorticoid, 
either prior to or shortly after migration to the adrenal pri-
mordium. The majority of these cells disappear by the first 
postnatal week, probably being eliminated by cell death (Henion 
and Landis, 1989). 
By the same token, at E 18.5 some SA l + cells can be found 
outside of the adrenal environment. Since the SA I ~ B2 switch 
appears to occur slowly and asynchronously, these cells may 
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have failed to induce 82 by El 6.5 and then have been prevented 
from doing so subsequently by the surge in fetal GC levels that 
occurs on E16.5-17.5 (Teitelman et al., 1982). The decision to 
retain the SAl antigen may, moreover, become stabilized with 
further chromaffin development. Interestingly, the SAl • cells in 
the paraaortic and extraadrenal region are found in clusters, as 
are the B2+ cells. This suggests that once cells decide whether 
or not to make the SAl _, B2 switch, they may reinforce their 
immediate neighbors to do likewise. Such a "community effect" 
has been demonstrated for the process of mesodermal induction 
in Amphibia (Gurdon, 1988). Alternatively, such clusters could 
reflect an aggregation (Henion and Landis, 1990) or clonal ex-
pansion of phenotypically similar cells. 
Using a series of antibody markers, we have defined a se-
quence of events during the development of the SA lineage in 
the rat embryo (Fig. 9). Bipotential SA progenitors initially coex-
press both chromaffin-specific and neuron-specific markers and 
then differentiate into neurons or endocrine cells depending upon 
the environment to which they migrate. Subsequently, addi-
tional changes in marker expression are detected: cells in the 
sympathetic ganglia switch from an SAl + to a B2+ phenotype, 
whereas this switch fails to occur for the majority of cells within 
the adrenal gland. Studies of isolated SA progenitors in vitro 
indicate that this switch correlates with a loss of competence to 
respond to glucocorticoids, an inducing signal for chromaffin 
differentiation. Taken together, these data indicate that the de-
velopment of sympathetic neurons and adrenal chromaffin cells 
is controlled not only by environmental signals, but also by 
changes in the ability of cells to respond to such signals. Such 
changes illustrate one way in which the developmental capacities 
of initially multipotent cells can become restricted during dif-
ferentiation. 
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